Brownstein Hyatt Farber Schreck is pleased to announce the addition of three new members to its Government Relations Department in Washington, D.C. Tracy Tolk joins as a policy director, Tim Shadyac joins as a senior policy advisor and Stephen Holland will be joining as senior counsel. This is the second group to join Brownstein from Crowell & Moring.
Brownstein recently announced five partners and a policy director joining the firm. Jim Flood, Aaron Cummings and Evan Chuck joined as shareholders in the firm’s Government Relations Department. Anne Elise Herold Li and Paul Keller joined as shareholders in the firm’s Intellectual Property Department. Scott Douglas joined the Government Relations Department as a policy director.
“We are thrilled to welcome Tracy, Tim and Stephen to Brownstein,” said Nadeam Elshami, co-chair of Brownstein’s Government Relations Department. “This group adds significant depth to our energy and health care practices and reflects the continued momentum of our growth. Following the recent addition of six other talented professionals, this group further strengthen our ability to deliver strategic, bipartisan solutions for our clients across the most complex policy landscapes.”
Tolk is a seasoned government affairs strategist with over 20 years of experience shaping policy at the highest levels of government. She advises clients on issues including energy, transportation, cybersecurity and Native American affairs, helping them secure federal funding and navigate complex legislative landscapes. Her expertise is rooted in her time on Capitol Hill, where she served under Reps. Jay Inslee (D-WA) and Jim Davis (D-FL), managing key policy portfolios and coordinating federal disaster response. In the private sector, she spent over 15 years representing electric utilities and clean energy innovators before Congress and federal agencies. Tolk also teaches legislative strategy as an adjunct professor at George Washington University’s Graduate School of Political Management.
Shadyac is an experienced lobbyist who advises clients at the intersection of business and public policy. He develops and executes legislative and regulatory strategies across health care, international trade, supply chain and emerging industries like cannabis. Having worked over a decade in health policy—shaped by early work in the life sciences sector on issues like drug pricing and Medicare Part D—Shadyac has become a trusted advisor to corporate leaders, offering strategic counsel informed by years of engagement with Congress, the White House and federal agencies.
Holland served over a decade in senior roles with the U.S. House of Representatives, where he played a central role in crafting major legislation related to the Food and Drug Administration (FDA), drug pricing and public health preparedness. As senior counsel on the House Energy and Commerce Committee, he led efforts on the Food and Drug Omnibus Reform Act of 2022 and helped secure billions in pandemic response funding through the CARES Act and other major bills. He also developed the Competitive Generic Therapy pathway at FDA, expanding access to affordable medicines. With Brownstein, Holland will advise clients on navigating the legislative process, shaping health policy and responding to congressional oversight.
“Joining the top bipartisan lobbying shop in the country is an exciting move in my career,” said Tolk. “Brownstein’s reputation for strategic insight, deep policy expertise and delivering real results is what drew me here.”
Recent Insights
Read MoreDissecting Colorado’s Ballot Measure Process
Client Alert | November 14, 2025Employee Benefits-Related Limits for 2026
Client Alert | November 13, 2025CR Signed, Sealed and Delivered: Government Reopens
Presentation | November 13, 2025Industry Knowledge and Software Technology Know-How Needed to Maximize Your Success During Tax Season and Beyond
Presentation | November 13, 2025Retirement and Employment Benefits
Client Alert | November 13, 2025Companies May Be Responsible for the Use of AI in Their Supply Chain Services
You have chosen to send an email to Brownstein Hyatt Farber Schreck or one of its lawyers. The sending and receipt of this email and the information in it does not in itself create and attorney-client relationship between us.
If you are not already a client, you should not provide us with information that you wish to have treated as privileged or confidential without first speaking to one of our lawyers.
If you provide information before we confirm that you are a client and that we are willing and able to represent you, we may not be required to treat that information as privileged, confidential, or protected information, and we may be able to represent a party adverse to you and even to use the information you submit to us against you.
I have read this and want to send an email.